Clinical Trials Directory

Trials / Completed

CompletedNCT01122576

Evaluation of 3 Intraocular Lenses Following Lens Extraction

A Three Arm Prospective Clinical Evaluation of Three FDA Approved Intraocular Lenses Designed to Improve Distance, Intermediate and Near Vision Following Lens Extraction.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
78 (actual)
Sponsor
Bausch & Lomb Incorporated · Industry
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the efficacy and subject satisfaction with three different FDA approved lenses for adults over 40 years of age who desire a reduction in spectacle dependence.

Conditions

Interventions

TypeNameDescription
DEVICECrystalens AOCrystalens AO surgically implanted bilaterally. Study observation up to 180 days.
DEVICEReSTORReSTOR surgically implanted bilaterally. Study observation up to 180 days.
DEVICETecnis Multifocal IOLTecnis surgically implanted bilaterally. Study observation up to 180 days.

Timeline

Start date
2010-06-01
Primary completion
2012-06-01
Completion
2012-09-01
First posted
2010-05-13
Last updated
2014-03-28
Results posted
2014-03-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01122576. Inclusion in this directory is not an endorsement.

Evaluation of 3 Intraocular Lenses Following Lens Extraction (NCT01122576) · Clinical Trials Directory